CODA Genomics Closes $1.6 Million Series B Financing
News Mar 01, 2006
CODA Genomics, Inc. has announced that it has closed a Series B funding of over $1.6 million. The round was led by the Life Science Angels, and includes venture capital firm Monitor Ventures and previous investors from the Tech Coast Angels.
The round has two representatives on the CODA Board of Directors, Ken Kelley from the Life Science Angels, and Neal Bhadkamkar from Monitor Ventures.
Dr. Robert J. Molinari, CEO of CODA comments, "We are delighted to have LSA and Monitor as our investment partners in CODA."
"LSA, with many experienced life science entrepreneurs as members, is ideally suited to identify and lead this investment. Monitor Ventures, with its extensive links and strategic insight into large biopharmaceutical clients can also greatly assist the company."
Kenneth Kelley said, "Life Science Angels is very excited about CODA's synthetic genes business. We believe their unique Translation Engineering™ solves many problems of protein expression and will be enabling of research in academia and in the biopharmaceutical industry."
Dr. Neal Bhadkamkar said, "Our team was excited by CODA for two reasons: robust, peer reviewed computational technology being applied to a fundamental problem that spans both life-science and industrial markets; and an outstanding team in every part of the company - science, operations, sales and the board."
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018